RETEVMO selpercatinib 80 mg immediate release capsules

Eli Lilly Australia Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 67c4a050db3233f6
Product Name: RETEVMO selpercatinib 80 mg immediate release capsules
Artg Id: 391330
Artg Name: RETEVMO selpercatinib 80 mg immediate release capsules
Sponsor: Eli Lilly Australia Pty Ltd
Company Detail Path: /organization/eli-lilly-australia-pty-ltd
Artg Date: 2023-07-03
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: REP
Consumer Medicine Info: http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2023-CMI-01913-1
Product Information: http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2023-PI-01883-1

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

67c4a050db3233f6

Type

Standard